Skip to content
For U.S. audiences only


For more than 70 years, Takeda has been dedicated to pursuing advancements in hemophilia care and empowering our community to find the treatment that’s right for them.1

Takeda commitment icon.

Additional RESOURCES

These organizations offer support for people with bleeding disorders and can help you connect with others and better understand your treatment options for hemophilia A.

Sign up for more information

Learn more about factor treatment and living with hemophilia by signing up for MyFactorFam emails.

  1. Takeda demonstrates its long-standing commitment to advancing treatments for rare bleeding disorders with studies highlighting real-world evidence and investigational gene therapy at ASH 2019. Takeda Pharmaceuticals. December 9, 2019. Accessed August 13, 2021.